Privi Speciality Chemicals Share Price Target 2027: 20.1% Upside to Rs 4,043, Bull Rs 4,842

Investors weighing a Privi Speciality Chemicals target price for 2027 should start with where the stock sits today. At Rs 3,366.90 on 12 November 2026, it is 11.1% below its 52-week high of Rs 3,785.30 and 31.0% above its 52-week low of Rs 2,570.80. That range spans 47% from low to high, so the entry point matters as much as the Privi Speciality Chemicals price forecast itself.

This article builds the Privi Speciality Chemicals share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario states its assumptions, so you can trace how the base case, the bull case and the downside risk level were reached and test them against your own view.

Click Here – Get Free Investment Predictions

Privi Speciality Chemicals Stock Analysis: Company Overview and Key Stats

Privi Speciality Chemicals (NSE: PRIVISCL) has a market capitalisation of Rs 13,160 crore. In FY26 it reported revenue of Rs 2,583 crore and net profit of Rs 316.72 crore. The table collects the figures the Privi Speciality Chemicals share price target is built on.

Metric	Value
Company	Privi Speciality Chemicals
NSE Ticker	PRIVISCL
CMP (12 November 2026)	Rs 3,366.90
52-Week High	Rs 3,785.30
52-Week Low	Rs 2,570.80
Market Cap	Rs 13,160 crore
PE Ratio (TTM)	35.63
Industry PE	33.54
Price to Book	8.35
Return on Equity	23.68%
Debt to Equity	0.63
EPS (TTM)	Rs 94.55
Dividend Yield	0.30%
12-Month Base Target	Rs 4,043
Bull Case	Rs 4,842
Downside Risk Level (not a target)	Rs 2,695

Why Is Privi Speciality Chemicals Share Price Target Set at Rs 4,043 for 2027?

The arithmetic is short. Trailing EPS of Rs 94.55 grown for one year gives a forward EPS estimate of Rs 113.46, and multiplying it by the unchanged PE of 35.63 gives the Rs 4,043 base-case Privi Speciality Chemicals stock target. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.

Earnings Growth Behind the Privi Speciality Chemicals Target Price: Five Years of Results

Privi Speciality Chemicals grew revenue from Rs 1,436 crore in FY22 to Rs 2,583 crore in FY26, a compound annual growth rate of 15.8%. Net profit grew faster, from Rs 97.38 crore to Rs 316.72 crore (34.3% a year), which shows margin gains did part of the work and not just higher sales.

Financial Year	Revenue (Rs Cr)	Net Profit (Rs Cr)	EPS (Rs)	Dividend per Share (Rs)
FY22	1,436.11	97.38	24.93	2.00
FY23	1,629.24	21.28	5.45	0.00
FY24	1,778.53	95.43	24.43	2.00
FY25	2,121.84	184.75	47.30	5.00
FY26	2,582.92	316.72	81.08	10.00

FY26 revenue growth was 21.7%, faster than the four-year average of 15.8%, and net profit moved up 71.4%. EPS rose from Rs 24.43 in FY24 to Rs 81.08 in FY26. The FY27 outlook for the Privi Speciality Chemicals price target depends on whether that EPS estimate keeps compounding.

Margins and the Latest Quarter

Privi Speciality Chemicals converted 12.3% of FY26 revenue into net profit, against 8.7% in FY25, within a five-year range of 1.3% to 12.3%. EBITDA margin was 25.8% in FY26 versus 22.3% in FY25.

In the September 2026 quarter, revenue was Rs 773.16 crore, up 13.9% from the same quarter a year earlier, while net profit of Rs 117.53 crore was up 30.3%. EBITDA came in at Rs 212.49 crore, up 16.7% year on year. The next quarterly result is the first test of whether the earnings assumption behind the Privi Speciality Chemicals stock target holds.

Balance Sheet and Cash Flow

Debt to equity stands at 0.63, and shareholders' equity grew from Rs 819.61 crore in FY22 to Rs 1,441 crore in FY26. Operating cash flow in FY26 was Rs 550.09 crore against capital expenditure of Rs 320.02 crore, leaving free cash flow of Rs 230.07 crore, or 1.7% of the current market capitalisation. In FY25 free cash flow was negative at Rs 18.03 crore, so cash generation has not been steady year to year.

Valuation Check for the Privi Speciality Chemicals Stock Target: PE, Price to Book and ROE

At a PE of 35.63 against an industry PE of 33.54, Privi Speciality Chemicals trades in line with its industry. Price to book is 8.35 on a book value of Rs 403.23 per share, and return on equity is 23.68%. A PE of 35.63 equals an earnings yield of 2.8%, and the FY26 dividend of Rs 10.00 per share gives a yield of 0.30%.

Shareholding Pattern and Institutional Holding

Promoters held 60.60% of Privi Speciality Chemicals in September 2026, and promoter holding fell from 69.89% in September 2025 to 60.60% in September 2026. Foreign institutional investors (FII) held 2.78% and domestic institutions (DII) held 8.96%, which puts total institutional holding at 11.74%. FII holding rose from 1.33% in September 2025 to 2.78% in September 2026. Public shareholders own the remaining 27.66%.

Privi Speciality Chemicals Share Price Targets for the Short Term and 12 Months

Short Term Privi Speciality Chemicals Stock Target Levels: Technical Setup

At Rs 3,366.90 on 12 November 2026, Privi Speciality Chemicals trades below its 50-day simple moving average of Rs 3,423.15 and above its 200-day exponential moving average of Rs 3,272.99. The 14-day RSI reads 55.9, which is neutral territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 3,423.15 (50-day simple moving average) and the nearest support is Rs 3,272.99 (200-day exponential moving average). A sustained move above Rs 3,423.15 would improve the short-term setup, while a close below Rs 3,272.99 would shift attention to the next support.

12 Month Privi Speciality Chemicals Target Price for 2027

The 12-month target of Rs 4,043 means a move of 20.1% up from Rs 3,366.90 over the next 12 months. It would also push the stock above its 52-week high of Rs 3,785.30. Anyone checking the Privi Speciality Chemicals share price target against their own view should focus on two inputs: the EPS estimate and the PE multiple.

How EPS Growth and PE Multiple Change the Privi Speciality Chemicals Target Price

EPS Growth	PE 28.50	PE 35.63	PE 40.97
0.0% (EPS Rs 94.55)	Rs 2,695	Rs 3,369	Rs 3,874
20.0% (EPS Rs 113.46)	Rs 3,234	Rs 4,043	Rs 4,648
25.0% (EPS Rs 118.19)	Rs 3,368	Rs 4,211	Rs 4,842

Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Privi Speciality Chemicals price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.

Bull Case and Downside Risk for Privi Speciality Chemicals Stock Target in 2027

Bull Case Rs 4,842

The bull case Privi Speciality Chemicals price target needs EPS growth of 25.0%, which lifts forward EPS to Rs 118.19, and a PE multiple that rises 15% to 40.97. That gives Rs 4,842, 43.8% above the current price and above the 52-week high of Rs 3,785.30, so the stock would have to set a fresh 52-week high.

Downside Risk Level Rs 2,695

The downside risk level is not a target. It assumes EPS stays flat at Rs 94.55 and the PE falls 20% to 28.50. That gives Rs 2,695, 20.0% below the current price and above the 52-week low of Rs 2,570.80.

Scenario	EPS Growth	PE Multiple	Price (Rs)	Change vs CMP
Bull Case	25.0%	40.97	Rs 4,842	+43.8%
Base Case	20.0%	35.63	Rs 4,043	+20.1%
Downside Risk	0.0%	28.50	Rs 2,695	-20.0%

Key Risks to the Privi Speciality Chemicals Target Price for 2027

Growth Slowdown Risk for the Privi Speciality Chemicals Price Target

Revenue in the September 2026 quarter was up 13.9% year on year, and FY26 revenue growth was 21.7%. If growth slows from here, the EPS estimate behind the Privi Speciality Chemicals stock target will need revising.

Liquidity and Size Risk

Privi Speciality Chemicals has a market capitalisation of Rs 13,160 crore. Institutional holding is 11.74%, and promoters hold 60.60%. Stocks of this size are usually liquid, though exits can take longer than entries when the market is falling.

Valuation and Margin Risk

Net margin was 12.3% in FY26, and a squeeze from higher costs or weaker pricing would hit earnings first. At a PE of 35.63 versus an industry PE of 33.54, a de-rating toward the downside-risk PE of 28.50 would cut the price even if earnings hold.

Market and Technical Risk

Technical indicators add short-term risk: the 14-day RSI is 55.9 and the MACD sits above its signal line. A broad fall in the Nifty 50 or the Sensex can override company fundamentals for weeks at a time.

How to Invest in Privi Speciality Chemicals

Start with the live price and volume. Any Privi Speciality Chemicals share price target is only as current as the data behind it, and the data here is as of 12 November 2026, so refresh the Rs 3,366.90 price before acting on any level.

Next, review the fundamentals yourself. The Univest Screener lets you check Privi Speciality Chemicals' PE, ROE, debt and shareholding in one place.

Check Privi Speciality Chemicals fundamentals on the Univest Screener

Then compare the three Privi Speciality Chemicals target price scenarios with your own view. If you expect EPS growth below 20.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.

Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.

Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.

Download the Univest iOS App or Univest Android App to track Privi Speciality Chemicals live price and get daily stock recommendations.

Conclusion

The Privi Speciality Chemicals share price target for 2027 is Rs 4,043 in the base case, with Rs 4,842 as the bull case. The support for that view is arithmetic you can check: EPS grew 82.2% a year over FY24 to FY26, and the stock trades at a PE of 35.63. The risks are equally concrete, including a valuation that can de-rate if growth disappoints and a downside scenario that cuts the price 20% if earnings stall. Use these numbers as a framework for judging the Privi Speciality Chemicals price target, check them against the latest filings, and size any position to your own risk appetite.

FAQs on Privi Speciality Chemicals Share Price Target 2027

What is the Privi Speciality Chemicals share price target for 2027?

Ans. The base-case Privi Speciality Chemicals share price target for 2027 is Rs 4,043, which is 20.1% above the price of Rs 3,366.90 on 12 November 2026. The bull case is Rs 4,842 and the downside risk level, which is not a target, is Rs 2,695. All three come from one method: forward EPS multiplied by a PE multiple, using only reported results. They are model estimates and not guaranteed outcomes, and the next quarterly result is the first check on the EPS assumption.

What is the Privi Speciality Chemicals share price today?

Ans. As of 12 November 2026, 9:28 AM IST, Privi Speciality Chemicals (NSE: PRIVISCL) trades at Rs 3,366.90, down 0.10% on the day. That is 11.1% below the 52-week high of Rs 3,785.30 and 31.0% above the 52-week low of Rs 2,570.80. The market capitalisation of Rs 13,160 crore places it among mid-cap stocks. Prices change through the trading session, so check the live quote before acting on any level in this article.

Is Privi Speciality Chemicals a buy or sell at the current price?

Ans. The data points both ways. On the positive side, EPS has grown 82.2% a year over FY24 to FY26 and the base case implies 20.1% upside; on the cautious side, the stock sits 11.1% below its 52-week high and can de-rate if growth disappoints, and the downside risk level of Rs 2,695 is 20% below the current price. Whether Privi Speciality Chemicals fits your portfolio depends on your time horizon, position size and risk appetite. Consult a SEBI-registered advisor before investing, as this article is not investment advice.

What are the bull case target and downside risk level for Privi Speciality Chemicals shares?

Ans. The bull case in the Privi Speciality Chemicals share price target for 2027 is Rs 4,842, which assumes 25.0% EPS growth and a PE of 40.97, a 15% re-rating from today's multiple. That is 43.8% above the current price and above the 52-week high of Rs 3,785.30, so the stock would have to set a fresh 52-week high. The downside risk level is Rs 2,695, which assumes flat EPS and a PE of 28.50, 20% lower than today. It sits 20.0% below the current price and above the 52-week low of Rs 2,570.80, and it marks a risk to watch, not a target.

What are the main risks to the Privi Speciality Chemicals price target?

Ans. Four risks matter most for the Privi Speciality Chemicals share price target: slower revenue or profit growth, a PE de-rating, thin liquidity or size risk, and weakness in the broader market. With a market capitalisation of Rs 13,160 crore, the stock is usually liquid, though exits can take longer than entries in a falling market. A fall to the downside-risk PE of 28.50 would cut the price even if earnings hold.

What is the PE ratio of Privi Speciality Chemicals and how does it compare with the industry?

Ans. The PE ratio of Privi Speciality Chemicals is 35.63, against an industry PE of 33.54, which is a level close to the industry. Price to book is 8.35 and return on equity is 23.68%, and the PE equals an earnings yield of 2.8%. The base case holds the PE unchanged, so the Privi Speciality Chemicals share price target moves only with earnings, while the bull and downside scenarios change the multiple by +15% and -20%.

Who owns Privi Speciality Chemicals, and what is the promoter holding?

Ans. Promoters held 60.60% of Privi Speciality Chemicals in September 2026. FII held 2.78%, DII held 8.96% and the public held 27.66%. Together the two institutional groups hold 11.74%. Shareholding is filed every quarter, so it is worth rechecking after each result.

What were Privi Speciality Chemicals' latest quarterly results?

Ans. In the September 2026 quarter, Privi Speciality Chemicals reported revenue of Rs 773.16 crore (up 13.9% year on year) and net profit of Rs 117.53 crore (up 30.3%). For comparison, FY26 full-year revenue growth was 21.7% and net profit moved up 71.4%. Each new quarter either supports or weakens the EPS growth of 20.0% assumed in the base case.